You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Amgen Inc. (AMGN $365.04)
- $365.04 P/E (TTM): 29.02X Cap: $196.35B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $762.14)
- $762.14 P/E (TTM): 18.81X Cap: $79.80B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $456.05)
- $456.05 P/E (TTM): 32.93X Cap: $117.59B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $170.19)
- $170.19 P/E (TTM): 20.63X Cap: $8.39B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,397.08)
- $1,397.08 P/E (TTM): 32.78X Cap: $28.46B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $6.29)
- $6.29 Cap: $507M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $12.26)
- $12.26 Cap: $61M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use